| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 2 | 3 | 2 | 1 | 4 | 3 | 3 | 5 | 2 | 1 | 8 | 2 |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 5,773.00 | 5,132.00 | 10,552.00 | 13,111.00 |
| Receivables | 4,332.00 | 6,192.00 | 6,315.00 | 7,281.00 |
| Inventory | 4,351.00 | 5,734.00 | 7,920.00 | 8,468.00 |
| Other | — | — | — | — |
| 16,768.00 | 19,049.00 | 26,947.00 | 31,522.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 2,418.00 | 2,466.00 | 2,929.00 | 5,359.00 |
| ST’ Debt | 751.00 | — | 874.00 | 875.00 |
| Other | 438.00 | 555.00 | 402.00 | 301.00 |
| 6,689.00 | 7,281.00 | 9,455.00 | 12,081.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 10,253.00 | 11,536.00 | — | — |
—
|
| ’25 | 7,438.00 | 7,685.00 | 9,246.00 | 10,270.00 |
34,639.00
|
| ’24 | 5,473.00 | 5,835.00 | 6,819.00 | 7,658.00 |
25,785.00
|
| ’23 | 5,353.00 | 5,359.00 | 5,800.00 | 6,168.00 |
22,680.00
|
| ’22 | 5,887.00 | 6,550.00 | 5,565.00 | 5,599.00 |
23,601.00
|
| ’21 | 3,445.00 | 3,850.00 | 4,313.00 | 4,826.00 |
16,434.00
|
| ’20 | 1,786.00 | 1,932.00 | 2,801.00 | 3,244.00 |
9,763.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,955.00 | 2,366.00 | — | — |
—
|
| ’25 | 939.00 | 2,011.00 | 2,159.00 | 2,600.00 |
7,709.00
|
| ’24 | 521.00 | 593.00 | 628.00 | 1,299.00 |
3,041.00
|
| ’23 | 486.00 | 379.00 | 421.00 | 381.00 |
1,667.00
|
| ’22 | 995.00 | 1,038.00 | 965.00 | 567.00 |
3,565.00
|
| ’21 | 898.00 | 952.00 | 849.00 | 822.00 |
3,521.00
|
| ’20 | (65.00) | 243.00 | 339.00 | 554.00 |
1,071.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,566.00 | 1,558.00 | — | — |
—
|
| ’25 | 727.00 | 1,707.00 | 1,923.00 | 2,340.00 |
6,697.00
|
| ’24 | 379.00 | 439.00 | 496.00 | 1,091.00 |
2,405.00
|
| ’23 | 328.00 | 254.00 | 297.00 | 242.00 |
1,121.00
|
| ’22 | 924.00 | 906.00 | 842.00 | 443.00 |
3,115.00
|
| ’21 | 832.00 | 888.00 | 764.00 | 736.00 |
3,220.00
|
| ’20 | (120.00) | 152.00 | 265.00 | 480.00 |
777.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.84 | 1.38 | — | — |
—
|
| ’25 | 0.44 | 0.54 | 0.75 | 0.92 |
2.65
|
| ’24 | 0.07 | 0.16 | 0.47 | 0.29 |
1.00
|
| ’23 | (0.09) | 0.02 | 0.18 | 0.41 |
0.53
|
| ’22 | 0.56 | 0.27 | 0.04 | 0.01 |
0.84
|
| ’21 | 0.45 | 0.58 | 0.75 | 0.80 |
2.57
|
| ’20 | 0.14 | 0.13 | 0.32 | 1.45 |
2.06
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 54.57 | 60.05 | 117.90 | 76.48 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 152.42 | 151.05 | 227.30 | 267.08 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25,000 | 26,000 | 28,000 | 31,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.94 | 0.87 | 0.92 | 1.12 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23,601.00 | 22,680.00 | 25,785.00 | 34,639.00 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.93% | 46.12% | 49.35% | 49.52% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,184.00 | 492.00 | 1,989.00 | 4,140.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.02% | 2.17% | 7.71% | 11.95% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,320.00 | 854.00 | 1,641.00 | 4,335.00 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,451.00 | 3,453.00 | 3,064.00 | 3,004.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.12 | 14.05 | 15.92 | 21.33 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 0.85 | 0.53 | 1.01 | 2.67 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.28 | 1.03 | 1.88 | 4.75 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.29) | (0.34) | (0.39) | (0.62) | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.00 | 0.69 | 1.48 | 4.12 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.07 | 34.63 | 35.54 | 38.79 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,561.00 | 1,614.00 | 1,620.00 | 1,624.00 | — | — | — |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 71.93 | 266.50 | 118.42 | 80.21 | — | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.23 | 9.86 | 7.59 | 10.04 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.83 | 4.00 | 3.40 | 5.52 | — | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.09 | 9.72 | 7.49 | 9.83 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.02 | 196.58 | 80.26 | 50.84 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,565.00 | 1,667.00 | 3,041.00 | 7,709.00 | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (450.00) | (546.00) | (636.00) | (1,012.00) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,115.00 | 1,121.00 | 2,405.00 | 6,697.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,650.00 | 10,079.00 | 11,768.00 | 17,492.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,560.00 | 2,468.00 | 1,721.00 | 3,222.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3,295.00) | (3,305.00) | (3,411.00) | (7,330.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54,750.00 | 55,892.00 | 57,568.00 | 62,999.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.30% | 1.26% | 2.39% | 5.93% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.54% | 0.48% | 2.19% | 4.15% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.24% | 1.54% | 2.89% | 7.19% | — | — | — |
ROE
|
Advanced Micro Devices (AMD) has evolved from a CPU underdog into a tech titan, rivaling Nvidia in GPUs and AI accelerators, with revenue exploding nearly 8x since 2016 to projected $34.6 billion in 2025—a staggering 34% YoY surge driven by Ryzen dominance, EPYC servers, Xilinx integration, and MI300 AI chips. Despite cyclical PC dips in 2023, recovery is underway with 2025 estimates showcasing revenue per employee climbing to $1.12 million, margins hitting a stellar 49%, and EPS poised for robust gains amid data center revenue now over 60%.
Profitability shines through: net income turnaround from losses to $4.34 billion forecasted, free cash flow per share rocketing 178% to $4.12, and a fortress balance sheet flipping to a $7.33 billion net cash position, fueling R&D and buybacks. Valuation looks rich at 105x forward PE but discounts Nvidia’s premium, with EV/FCF at 51x signaling re-rating potential as AI ramps—analysts eye 20-30% upside on execution.
Insider selling dominates (routine profit-taking), yet a key EVP buy signals confidence, aligning with consensus targets implying strong gains if MI300/EPYC deliver. AMD’s decade-long arc screams disruptive winner—don’t miss the AI frenzy; dive into the full analysis for the numbers that could supercharge your portfolio!
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.